Rituximab-Induced Severe Acute Thrombocytopenia: A case Report and Review of Literature
Rituximab, an anti-CD20 monoclonal antibody, is generally a safe and well-tolerated drug. Severe acute thrombocytopenia following administration of rituximab is a rare phenomenon, with few previously reported cases in the literature. We report a case of an 84-year old male with a diagnosis of mantle...
Gespeichert in:
| Veröffentlicht in: | Cancer investigation 2008-01, Vol.26 (9), p.913-915 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 915 |
|---|---|
| container_issue | 9 |
| container_start_page | 913 |
| container_title | Cancer investigation |
| container_volume | 26 |
| creator | Dhand, Suneel Bahrain, Huzefa |
| description | Rituximab, an anti-CD20 monoclonal antibody, is generally a safe and well-tolerated drug. Severe acute thrombocytopenia following administration of rituximab is a rare phenomenon, with few previously reported cases in the literature. We report a case of an 84-year old male with a diagnosis of mantle cell lymphoma who suffered severe acute thrombocytopenia following rituximab infusion. A literature review of the previously published cases is also presented. |
| doi_str_mv | 10.1080/07357900802010509 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1080_07357900802010509</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69826856</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-18c39b193aecec65071afb05ee8bc2895e0be68fbaa49d8ea155ff035a027f8d3</originalsourceid><addsrcrecordid>eNp9kEGLFDEQhYMo7rj6A7xITt5aK51JJ1Evw7LqwoCwrngM1ekK00t3Z0zSu86_t5cZEBH2VA_qe4-qx9hrAe8EGHgPWiptYZE1CFBgn7CVULKu1sLWT9nqYV8tgD5jL3K-BRCm1uo5OxMW5FpruWI_r_sy_-5HbKurqZs9dfw73VEivvFzIX6zS3Fsoz-UuKepxw98wz1m4te0j6lwnLpF3vV0z2Pg275QwjInesmeBRwyvTrNc_bj8-XNxddq--3L1cVmW_m1hlIJ46VthZVInnyjQAsMLSgi0_raWEXQUmNCi7i2nSEUSoUAUiHUOphOnrO3x9x9ir9mysWNffY0DDhRnLNrrKkbo5oFFEfQp5hzouD2aXk7HZwA99Cm-6_NxfPmFD63I3V_Haf6FuDTEeinENOI9zENnSt4GGIKCSffZycfy__4j31HOJSdx0TuNs5pWop75Lo__oiVag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69826856</pqid></control><display><type>article</type><title>Rituximab-Induced Severe Acute Thrombocytopenia: A case Report and Review of Literature</title><source>Taylor & Francis:Master (3349 titles)</source><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><creator>Dhand, Suneel ; Bahrain, Huzefa</creator><creatorcontrib>Dhand, Suneel ; Bahrain, Huzefa</creatorcontrib><description>Rituximab, an anti-CD20 monoclonal antibody, is generally a safe and well-tolerated drug. Severe acute thrombocytopenia following administration of rituximab is a rare phenomenon, with few previously reported cases in the literature. We report a case of an 84-year old male with a diagnosis of mantle cell lymphoma who suffered severe acute thrombocytopenia following rituximab infusion. A literature review of the previously published cases is also presented.</description><identifier>ISSN: 0735-7907</identifier><identifier>EISSN: 1532-4192</identifier><identifier>DOI: 10.1080/07357900802010509</identifier><identifier>PMID: 19034773</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal - administration & dosage ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Murine-Derived ; Antineoplastic Agents - adverse effects ; Female ; Humans ; Lymphoma, Mantle-Cell - drug therapy ; Lymphoma, Mantle-Cell - pathology ; Male ; Mantle cell lymphoma ; Middle Aged ; Rituximab ; Thrombocytopenia ; Thrombocytopenia - blood ; Thrombocytopenia - diagnosis ; Thrombocytopenia - etiology</subject><ispartof>Cancer investigation, 2008-01, Vol.26 (9), p.913-915</ispartof><rights>2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-18c39b193aecec65071afb05ee8bc2895e0be68fbaa49d8ea155ff035a027f8d3</citedby><cites>FETCH-LOGICAL-c470t-18c39b193aecec65071afb05ee8bc2895e0be68fbaa49d8ea155ff035a027f8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/07357900802010509$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/07357900802010509$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,59620,59726,60409,60515,61194,61229,61375,61410</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19034773$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dhand, Suneel</creatorcontrib><creatorcontrib>Bahrain, Huzefa</creatorcontrib><title>Rituximab-Induced Severe Acute Thrombocytopenia: A case Report and Review of Literature</title><title>Cancer investigation</title><addtitle>Cancer Invest</addtitle><description>Rituximab, an anti-CD20 monoclonal antibody, is generally a safe and well-tolerated drug. Severe acute thrombocytopenia following administration of rituximab is a rare phenomenon, with few previously reported cases in the literature. We report a case of an 84-year old male with a diagnosis of mantle cell lymphoma who suffered severe acute thrombocytopenia following rituximab infusion. A literature review of the previously published cases is also presented.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Monoclonal - administration & dosage</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphoma, Mantle-Cell - drug therapy</subject><subject>Lymphoma, Mantle-Cell - pathology</subject><subject>Male</subject><subject>Mantle cell lymphoma</subject><subject>Middle Aged</subject><subject>Rituximab</subject><subject>Thrombocytopenia</subject><subject>Thrombocytopenia - blood</subject><subject>Thrombocytopenia - diagnosis</subject><subject>Thrombocytopenia - etiology</subject><issn>0735-7907</issn><issn>1532-4192</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEGLFDEQhYMo7rj6A7xITt5aK51JJ1Evw7LqwoCwrngM1ekK00t3Z0zSu86_t5cZEBH2VA_qe4-qx9hrAe8EGHgPWiptYZE1CFBgn7CVULKu1sLWT9nqYV8tgD5jL3K-BRCm1uo5OxMW5FpruWI_r_sy_-5HbKurqZs9dfw73VEivvFzIX6zS3Fsoz-UuKepxw98wz1m4te0j6lwnLpF3vV0z2Pg275QwjInesmeBRwyvTrNc_bj8-XNxddq--3L1cVmW_m1hlIJ46VthZVInnyjQAsMLSgi0_raWEXQUmNCi7i2nSEUSoUAUiHUOphOnrO3x9x9ir9mysWNffY0DDhRnLNrrKkbo5oFFEfQp5hzouD2aXk7HZwA99Cm-6_NxfPmFD63I3V_Haf6FuDTEeinENOI9zENnSt4GGIKCSffZycfy__4j31HOJSdx0TuNs5pWop75Lo__oiVag</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Dhand, Suneel</creator><creator>Bahrain, Huzefa</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Rituximab-Induced Severe Acute Thrombocytopenia: A case Report and Review of Literature</title><author>Dhand, Suneel ; Bahrain, Huzefa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-18c39b193aecec65071afb05ee8bc2895e0be68fbaa49d8ea155ff035a027f8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Monoclonal - administration & dosage</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphoma, Mantle-Cell - drug therapy</topic><topic>Lymphoma, Mantle-Cell - pathology</topic><topic>Male</topic><topic>Mantle cell lymphoma</topic><topic>Middle Aged</topic><topic>Rituximab</topic><topic>Thrombocytopenia</topic><topic>Thrombocytopenia - blood</topic><topic>Thrombocytopenia - diagnosis</topic><topic>Thrombocytopenia - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dhand, Suneel</creatorcontrib><creatorcontrib>Bahrain, Huzefa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dhand, Suneel</au><au>Bahrain, Huzefa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rituximab-Induced Severe Acute Thrombocytopenia: A case Report and Review of Literature</atitle><jtitle>Cancer investigation</jtitle><addtitle>Cancer Invest</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>26</volume><issue>9</issue><spage>913</spage><epage>915</epage><pages>913-915</pages><issn>0735-7907</issn><eissn>1532-4192</eissn><abstract>Rituximab, an anti-CD20 monoclonal antibody, is generally a safe and well-tolerated drug. Severe acute thrombocytopenia following administration of rituximab is a rare phenomenon, with few previously reported cases in the literature. We report a case of an 84-year old male with a diagnosis of mantle cell lymphoma who suffered severe acute thrombocytopenia following rituximab infusion. A literature review of the previously published cases is also presented.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>19034773</pmid><doi>10.1080/07357900802010509</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-7907 |
| ispartof | Cancer investigation, 2008-01, Vol.26 (9), p.913-915 |
| issn | 0735-7907 1532-4192 |
| language | eng |
| recordid | cdi_informahealthcare_journals_10_1080_07357900802010509 |
| source | Taylor & Francis:Master (3349 titles); MEDLINE; Taylor & Francis Medical Library - CRKN |
| subjects | Adult Aged Aged, 80 and over Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents - adverse effects Female Humans Lymphoma, Mantle-Cell - drug therapy Lymphoma, Mantle-Cell - pathology Male Mantle cell lymphoma Middle Aged Rituximab Thrombocytopenia Thrombocytopenia - blood Thrombocytopenia - diagnosis Thrombocytopenia - etiology |
| title | Rituximab-Induced Severe Acute Thrombocytopenia: A case Report and Review of Literature |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T22%3A26%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rituximab-Induced%20Severe%20Acute%20Thrombocytopenia:%20A%20case%20Report%20and%20Review%20of%20Literature&rft.jtitle=Cancer%20investigation&rft.au=Dhand,%20Suneel&rft.date=2008-01-01&rft.volume=26&rft.issue=9&rft.spage=913&rft.epage=915&rft.pages=913-915&rft.issn=0735-7907&rft.eissn=1532-4192&rft_id=info:doi/10.1080/07357900802010509&rft_dat=%3Cproquest_infor%3E69826856%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69826856&rft_id=info:pmid/19034773&rfr_iscdi=true |